Free Trial

Healthpeak Properties, Inc. $DOC Holdings Boosted by Barclays PLC

Healthpeak Properties logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Barclays increased its stake in Healthpeak Properties by 7.0% to 1,495,525 shares (about $28.6M), and overall institutional ownership is very high at 93.57% with large additions from State Street and a 41.0% increase by JPMorgan (adding 8.21M shares).
  • Healthpeak beat quarterly estimates ($0.47 EPS vs. $0.45 expected; revenue $719.4M vs. $685.1M) and set FY2026 guidance of $1.70–$1.74 EPS, while analysts hold a consensus rating of Hold with a $19.42 target.
  • The company declared a monthly dividend of $0.1017 per share (annualized yield ~7.1%), though the reported payout ratio is extremely high at 1,220%.
  • Interested in Healthpeak Properties? Here are five stocks we like better.

Barclays PLC boosted its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 7.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,495,525 shares of the real estate investment trust's stock after purchasing an additional 97,662 shares during the quarter. Barclays PLC owned approximately 0.22% of Healthpeak Properties worth $28,639,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in DOC. State Street Corp grew its holdings in Healthpeak Properties by 0.9% in the 2nd quarter. State Street Corp now owns 48,602,649 shares of the real estate investment trust's stock worth $851,032,000 after buying an additional 442,481 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Healthpeak Properties by 41.0% during the third quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust's stock valued at $540,730,000 after purchasing an additional 8,212,504 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Healthpeak Properties by 1.0% in the second quarter. Geode Capital Management LLC now owns 19,071,094 shares of the real estate investment trust's stock worth $332,625,000 after purchasing an additional 197,540 shares during the period. Charles Schwab Investment Management Inc. grew its position in Healthpeak Properties by 2.8% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 10,520,156 shares of the real estate investment trust's stock valued at $184,208,000 after buying an additional 282,155 shares in the last quarter. Finally, Cullen Capital Management LLC increased its stake in Healthpeak Properties by 6.7% during the 3rd quarter. Cullen Capital Management LLC now owns 10,232,875 shares of the real estate investment trust's stock valued at $195,960,000 after buying an additional 641,771 shares during the period. 93.57% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages have recently issued reports on DOC. Argus cut Healthpeak Properties from a "buy" rating to a "hold" rating in a research report on Thursday, February 5th. The Goldman Sachs Group assumed coverage on shares of Healthpeak Properties in a report on Friday, January 9th. They issued a "neutral" rating and a $17.00 target price on the stock. Weiss Ratings upgraded shares of Healthpeak Properties from a "sell (d+)" rating to a "hold (c-)" rating in a report on Monday, January 26th. Wells Fargo & Company restated a "positive" rating on shares of Healthpeak Properties in a research report on Tuesday, February 3rd. Finally, Cantor Fitzgerald set a $17.00 price objective on Healthpeak Properties in a research report on Monday, January 5th. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $19.42.

Get Our Latest Report on Healthpeak Properties

Healthpeak Properties Stock Performance

Shares of DOC opened at $17.08 on Thursday. The company has a market capitalization of $11.87 billion, a PE ratio of 170.77, a PEG ratio of 9.31 and a beta of 1.12. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.82 and a current ratio of 2.82. The company's 50 day moving average price is $17.16 and its 200 day moving average price is $17.58. Healthpeak Properties, Inc. has a 52 week low of $15.71 and a 52 week high of $20.81.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.45 by $0.02. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The company had revenue of $719.40 million for the quarter, compared to analyst estimates of $685.14 million. During the same period in the prior year, the firm posted $0.46 EPS. The business's revenue was up 3.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. Research analysts expect that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be issued a dividend of $0.1017 per share. The ex-dividend date is Tuesday, March 17th. This represents a c) dividend on an annualized basis and a dividend yield of 7.1%. Healthpeak Properties's payout ratio is 1,220.00%.

About Healthpeak Properties

(Free Report)

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

Read More

Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Healthpeak Properties Right Now?

Before you consider Healthpeak Properties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.

While Healthpeak Properties currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines